← Back to Search
Extraocular Muscle Is Spared Despite The Absence Of An Intact Sarcoglycan Complex In γ- Or δ-sarcoglycan-deficient Mice
J. Porter, A. P. Merriam, A. A. Hack, F. H. Andrade, E. McNally
Published 2001 · Biology
Download PDFAnalyze on Scholarcy
Abstract Models of the dystrophin–glycoprotein complex do not reconcile the novel sparing of extraocular muscle in muscular dystrophy. Extraocular muscle sparing in Duchenne muscular dystrophy implies the existence of adaptive properties in these muscles that may extend protection to other neuromuscular diseases. We studied the extraocular muscle morphology and dystrophin–glycoprotein complex organization in murine targeted deletion of the γ-sarcoglycan (gsg−/−) and δ-sarcoglycan (dsg−/−) genes, two models of autosomal recessive limb girdle muscular dystrophy. In contrast to limb and diaphragm, the principal extraocular muscles were intact in gsg−/− and dsg−/− mice. However, central nucleated, presumptive regenerative, fibers were seen in the accessory extraocular muscles (retractor bulbi, levator palpebrae superioris) of both strains. Skeletal muscles of gsg−/− mice exhibited in vivo Evans Blue dye permeability, while the principal extraocular muscles did not. Disruption of γ-sarcoglycan produced secondary displacement of α- and β-sarcoglycans in the extraocular muscles. The intensity of immunofluorescence for dystrophin and α- and β-dystroglycan also appeared to be slightly reduced. Utrophin localization was unchanged. The finding that sarcoglycan disruption was insufficient to elicit alterations in extraocular muscle suggests that loss of mechanical stability and increased sarcolemmal permeability are not inevitable consequences of mutations that disrupt the dystrophin–glycoprotein complex organization and must be accounted for in models of muscular dystrophy.
This paper references
Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage
K. Campbell (1995)
Spatial and temporal patterns of myosin heavy chain expression in developing rat extraocular muscle
J. Brueckner (2004)
Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex
R. Crosbie (1999)
The clinical spectrum of sarcoglycanopathies
C. Angelini (1999)
Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels
J. Schultz (1998)
β–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12
L. E. Lim (1995)
The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin.
J. Porter (1998)
Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice.
K. Araishi (1999)
Small‐caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy
G. Karpati (1988)
Ecto-ATPase Activity of α-Sarcoglycan (Adhalin)*
R. Betto (1999)
Morphologic changes in extraocular muscles of the dystrophic hamster
D. Percy (1979)
Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption
V. Straub (1997)
Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy
C. Webster (1988)
Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy
A. Deconinck (1997)
SH3 Domain-mediated Interaction of Dystroglycan and Grb2(*)
B. Yang (1995)
The 87K postsynaptic membrane protein from torpedo is a protein-tyrosine kinase substrate homologous to dystrophin
K. Wagner (1993)
THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: I. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATION
G. Coulton (1988)
beta-dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations.
M. F. Peters (1997)
Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy
R. Grady (1997)
Muscular dystrophies and the dystrophin-glycoprotein complex.
V. Straub (1997)
Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase
M. Wehling (1998)
Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy.
M. Yoshida (2000)
Fiber regeneration is not persistent in dystrophic (MDX) mouse skeletal muscle.
J. Dimario (1991)
Visual system maldevelopment disrupts extraocular muscle-specific myosin expression.
J. Brueckner (1998)
Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains
J. Brenman (1996)
Identification of the Syrian hamster cardiomyopathy gene.
V. Nigro (1997)
Fibres of intermediate type 1C and 2C are found continuously in mdx soleus muscle up to 52 weeks
C. Pastoret (2004)
Animal models of muscular dystrophy – what can they teach us?
T. Partridge (1991)
Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E).
C. Bönnemann (1996)
Structural organization of the extraocular muscles.
Spencer Rf (1988)
Extraocular muscles are spared in advanced duchenne dystrophy
Henry J. Kaminski (1992)
Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.
R. Matsuda (1995)
Characterization of the tyrosine phosphorylation and distribution of dystrobrevin isoforms
S. Balasubramanian (1998)
Morphological fiber types of retractor bulbi muscle in mouse and rat.
B. Pachter (1976)
Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle
K. Matsumura (1992)
Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice
K. Ohlendieck (1991)
Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression.
G. Karpati (1986)
Dynamic properties of inferior rectus muscle of the rat
R. Close (1974)
Progressive depletion of fast alpha‐actinin‐positive muscle fibers in Duchenne muscular dystrophy
C. Minetti (1991)
Abnormalities in α-, β- and γ-sarcoglycan in patients with limb-girdle muscular dystrophy
C. Sewry (1996)
Ca-Calmodulin Binds to the Carboxyl-terminal Domain of Dystrophin (*)
J. T. Anderson (1996)
γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin
A. A. Hack (1998)
Mutations in the sarcoglycan genes in patients with myopathy.
D. Duggan (1997)
Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D).
A. Carrié (1997)
Muscles of a different 'color'
J. Porter (1996)
Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.
P. Vachon (1997)
Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy
R. Coral-Vázquez (1999)
The oculomotor periphery: the clinician's focus is no longer a basic science stepchild
J. Porter (1997)
A PDZ-containing Scaffold Related to the Dystrophin Complex at the Basolateral Membrane of Epithelial Cells
A. M. Kachinsky (1999)
Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm.
B. Petrof (1993)
Eye muscle sparing by the muscular dystrophies: Lessons to be learned?
F. H. Andrade (2000)
Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies
R. Grady (1999)
From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy
E. Ozawa (1998)
Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy
S. Roberds (1994)
Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing
T. Khurana (1995)
Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice
F. Duclos (1998)
Commentary: extraocular muscle sparing in muscular dystrophy: a critical evaluation of potential protective mechanisms
J. Porter (1998)
Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy
S. Noguchi (1995)
Extraocular, limb and diaphragm muscle group-specific antioxidant enzyme activity patterns in control and mdx mice
R. J. Ragusa (1996)
Mutations That Disrupt the Carboxyl-Terminus of γ-Sarcoglycan Cause Muscular Dystrophy
E. McNally (1996)
Dystrophin–glycoprotein complex: Its role in the molecular pathogenesis of muscular dystrophies
K. Matsumura (1994)
This paper is referenced by
Microarray analysis of normal and dystrophic skeletal muscle
J. N. Haslett (2002)
Conserved and muscle-group-specific gene expression patterns shape postnatal development of the novel extraocular muscle phenotype.
G. Cheng (2004)
Extraocular muscle is defined by a fundamentally distinct gene expression profile
J. Porter (2001)
Nebulin isoforms of extraocular muscle
C. L. Moncman (2006)
Extraocular Muscle: Cellular Adaptations for a Diverse Functional Repertoire
J. Porter (2002)
Laminin isoforms in human extraocular muscles.
D. Kjellgren (2004)
Differential Susceptibility of the Ocular Motor System to Disease
H. Kaminski (2002)
Frequency of dystrophic muscle abnormalities in chronic progressive external ophthalmoplegia: analysis of 86 patients
B. H. Kiyomoto (2006)
Sparing of the extraocular muscles in mdx mice with absent or reduced utrophin expression: A life span analysis
Abby A. McDonald (2015)
The neuroanatomical basis of oculomotor disorders: the dual motor control of extraocular muscles and its possible role in proprioception
J. Büttner-Ennever (2002)
Sparing of extraocular muscle in aging and muscular dystrophies: a myogenic precursor cell hypothesis.
Kristen M Kallestad (2011)
The Extraocular Muscles
L. McLoon (2011)
Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
K. Gawlik (2014)
Eliminating the Ant1 isoform produces a mouse with CPEO pathology but normal ocular motility.
Hang Yin (2005)
Distinctive morphological and gene/protein expression signatures during myogenesis in novel cell lines from extraocular and hindlimb muscle.
J. Porter (2006)
Molecular organization of the extraocular muscle neuromuscular junction: partial conservation of and divergence from the skeletal muscle prototype.
S. Khanna (2003)
Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice
J. Porter (2003)
Fiber Types in Rat Laryngeal Muscles and Their Transformations After Denervation and Reinnervation
H. Rhee (2004)
Bupivacaine Myotoxicity Is Mediated by Mitochondria*
William C Irwin (2002)
Expression of cardiac α-actin spares extraocular muscles in skeletal muscle α-actin diseases – Quantification of striated α-actins by MRM-mass spectrometry
G. Ravenscroft (2008)
Comparison of the Craniofacial Muscles: A Unifying Hypothesis
Linda K McLoon (2012)
Analysis of human sarcospan as a candidate gene for CFEOM1
K. O'Brien (2000)
Myogenic precursor cells in the extraocular muscles
Kristen M Kallestad (2008)
Extraocular muscle satellite cells are high performance myo-engines retaining efficient regenerative capacity in dystrophin deficiency.
Pascal Stuelsatz (2015)
Postnatal suppression of myomesin, muscle creatine kinase and the M-line in rat extraocular muscle
J. Porter (2003)
Biological organization of the extraocular muscles.
R. Spencer (2006)
Barx homeobox family in muscle development and regeneration.
H. Makarenkova (2012)
Delayed synapse elimination in mouse levator palpebrae superioris muscle
M. A. Fox (2011)
Neuroanatomie des okulomotorischen Systems
S. Heermann (2017)
Intrinsic laryngeal muscles are spared from degeneration in the dy3k/dy3k mouse model of congenital muscular dystrophy type 1A
M. Häger (2009)
extraocular and hindlimb muscle signatures during myogenesis in novel cell lines from Distinctive morphological and gene/protein expression
Sangeeta Khanna (2015)
Transcriptional profile of rat extraocular muscle by serial analysis of gene expression.
G. Cheng (2002)See more